
Nora Maureen Rooney
Examiner (ID: 2608, Phone: (571)272-9937 , Office: P/1644 )
| Most Active Art Unit | 1644 |
| Art Unit(s) | 1641, 1644 |
| Total Applications | 916 |
| Issued Applications | 453 |
| Pending Applications | 111 |
| Abandoned Applications | 388 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 9197729
[patent_doc_number] => 20130337044
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-12-19
[patent_title] => 'MODULATION OF EFFECTOR T CELL RESPONSES BY LOCAL DEPLETION OF COMPLEMENT COMPONENT C3'
[patent_app_type] => utility
[patent_app_number] => 13/917703
[patent_app_country] => US
[patent_app_date] => 2013-06-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 39459
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13917703
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/917703 | MODULATION OF EFFECTOR T CELL RESPONSES BY LOCAL DEPLETION OF COMPLEMENT COMPONENT C3 | Jun 13, 2013 | Abandoned |
Array
(
[id] => 9537175
[patent_doc_number] => 20140161823
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-12
[patent_title] => 'COMPOSITIONS AND METHODS FOR DIAGNOSING AND TREATING AN INFLAMMATION'
[patent_app_type] => utility
[patent_app_number] => 13/913587
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 14106
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913587
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913587 | Compositions and methods for diagnosing and treating an inflammation | Jun 9, 2013 | Issued |
Array
(
[id] => 9977041
[patent_doc_number] => 09023349
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2015-05-05
[patent_title] => 'Compositions and methods for diagnosing and treating an inflammation'
[patent_app_type] => utility
[patent_app_number] => 13/913578
[patent_app_country] => US
[patent_app_date] => 2013-06-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 19
[patent_no_of_words] => 26882
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13913578
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/913578 | Compositions and methods for diagnosing and treating an inflammation | Jun 9, 2013 | Issued |
Array
(
[id] => 10213978
[patent_doc_number] => 20150098969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-09
[patent_title] => 'ALTERNARIA PEPTIDES'
[patent_app_type] => utility
[patent_app_number] => 14/403464
[patent_app_country] => US
[patent_app_date] => 2013-05-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20506
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14403464
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/403464 | ALTERNARIA PEPTIDES | May 29, 2013 | Abandoned |
Array
(
[id] => 12562719
[patent_doc_number] => 10016475
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-10
[patent_title] => Composition for preventing, improving, or treating immune diseases comprising natural extracts as active ingredients
[patent_app_type] => utility
[patent_app_number] => 14/404631
[patent_app_country] => US
[patent_app_date] => 2013-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 13388
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14404631
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/404631 | Composition for preventing, improving, or treating immune diseases comprising natural extracts as active ingredients | May 28, 2013 | Issued |
Array
(
[id] => 9042287
[patent_doc_number] => 20130244925
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-09-19
[patent_title] => 'MOLECULES MIMICKING AN AUTOANTIBODY IDIOTYPE AND COMPOSITIONS CONTAINING SAME'
[patent_app_type] => utility
[patent_app_number] => 13/902836
[patent_app_country] => US
[patent_app_date] => 2013-05-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 9021
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13902836
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/902836 | Molecules mimicking an autoantibody idiotype and compositions containing same | May 25, 2013 | Issued |
Array
(
[id] => 11178949
[patent_doc_number] => 09410938
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-08-09
[patent_title] => 'Biomarkers for asthma'
[patent_app_type] => utility
[patent_app_number] => 13/893425
[patent_app_country] => US
[patent_app_date] => 2013-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 3846
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 117
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13893425
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/893425 | Biomarkers for asthma | May 13, 2013 | Issued |
Array
(
[id] => 10225827
[patent_doc_number] => 20150110819
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'T CELL EPITOPES FROM COCKROACH AND METHODS OF MAKING AND USING SAME'
[patent_app_type] => utility
[patent_app_number] => 14/398719
[patent_app_country] => US
[patent_app_date] => 2013-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 46970
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398719
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398719 | T cell epitopes from Cockroach and methods of making and using same | May 2, 2013 | Issued |
Array
(
[id] => 10201605
[patent_doc_number] => 20150086594
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-26
[patent_title] => 'ANTI-ALLERGIC MEDICAMENT'
[patent_app_type] => utility
[patent_app_number] => 14/398209
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7379
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398209
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398209 | ANTI-ALLERGIC MEDICAMENT | May 1, 2013 | Abandoned |
Array
(
[id] => 9134384
[patent_doc_number] => 20130295097
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-11-07
[patent_title] => 'Human Antibodies to Fel d1 and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 13/875401
[patent_app_country] => US
[patent_app_date] => 2013-05-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37448
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13875401
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/875401 | Human antibodies to Fel d1 and methods of use thereof | May 1, 2013 | Issued |
Array
(
[id] => 11779140
[patent_doc_number] => 09388236
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2016-07-12
[patent_title] => 'Methods for reducing allergies caused by environmental allergens'
[patent_app_type] => utility
[patent_app_number] => 13/870374
[patent_app_country] => US
[patent_app_date] => 2013-04-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9599
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 149
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13870374
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/870374 | Methods for reducing allergies caused by environmental allergens | Apr 24, 2013 | Issued |
Array
(
[id] => 10233243
[patent_doc_number] => 20150118237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-30
[patent_title] => 'ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES'
[patent_app_type] => utility
[patent_app_number] => 14/396521
[patent_app_country] => US
[patent_app_date] => 2013-04-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 15077
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14396521
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/396521 | ANTI-HUMAN CD69 ANTIBODY, AND USE THEREOF FOR MEDICAL PURPOSES | Apr 22, 2013 | Abandoned |
Array
(
[id] => 10225825
[patent_doc_number] => 20150110818
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-04-23
[patent_title] => 'METHOD FOR PRESYMPTOMATIC DIAGNOSIS OF COELIAC DISEASE AND GLUTEN SENSITIVITY'
[patent_app_type] => utility
[patent_app_number] => 14/395353
[patent_app_country] => US
[patent_app_date] => 2013-04-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 5876
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14395353
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/395353 | Method for presymptomatic diagnosis of coeliac disease and gluten sensitivity | Apr 16, 2013 | Issued |
Array
(
[id] => 10241464
[patent_doc_number] => 20150126459
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-05-07
[patent_title] => 'PLANT PROFILIN POLYPEPTIDES FOR USE IN NON-SPECIFIC ALLERGY IMMUNOTHERAPY'
[patent_app_type] => utility
[patent_app_number] => 14/391777
[patent_app_country] => US
[patent_app_date] => 2013-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 39936
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14391777
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/391777 | PLANT PROFILIN POLYPEPTIDES FOR USE IN NON-SPECIFIC ALLERGY IMMUNOTHERAPY | Apr 15, 2013 | Abandoned |
Array
(
[id] => 9518789
[patent_doc_number] => 20140155281
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2014-06-05
[patent_title] => 'Method of assessing infection status'
[patent_app_type] => utility
[patent_app_number] => 13/859438
[patent_app_country] => US
[patent_app_date] => 2013-04-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 18
[patent_figures_cnt] => 18
[patent_no_of_words] => 11889
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13859438
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/859438 | Method of assessing infection status | Apr 8, 2013 | Abandoned |
Array
(
[id] => 9916762
[patent_doc_number] => 20150071967
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2015-03-12
[patent_title] => 'Tolerisation-Inducing Composition'
[patent_app_type] => utility
[patent_app_number] => 14/389861
[patent_app_country] => US
[patent_app_date] => 2013-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 7532
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14389861
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/389861 | Tolerisation-Inducing Composition | Apr 1, 2013 | Abandoned |
Array
(
[id] => 10574171
[patent_doc_number] => 09296798
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2016-03-29
[patent_title] => 'Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods'
[patent_app_type] => utility
[patent_app_number] => 13/851192
[patent_app_country] => US
[patent_app_date] => 2013-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 3
[patent_no_of_words] => 7282
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13851192
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/851192 | Purified linear epitopes from cashew nuts, nucleic acids encoding therefor, and associated methods | Mar 26, 2013 | Issued |
Array
(
[id] => 13151883
[patent_doc_number] => 10092646
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-10-09
[patent_title] => Compositions and methods for beta-glucan immunotherapy
[patent_app_type] => utility
[patent_app_number] => 14/398020
[patent_app_country] => US
[patent_app_date] => 2013-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 11
[patent_no_of_words] => 7577
[patent_no_of_claims] => 13
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 36
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14398020
[rel_patent_id] =>[rel_patent_doc_number] =>) 14/398020 | Compositions and methods for beta-glucan immunotherapy | Mar 13, 2013 | Issued |
Array
(
[id] => 11581796
[patent_doc_number] => 09636415
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-05-02
[patent_title] => 'Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies'
[patent_app_type] => utility
[patent_app_number] => 13/791824
[patent_app_country] => US
[patent_app_date] => 2013-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 21346
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 61
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13791824
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/791824 | Bispecific molecule binding TLR9 and CD32 and comprising a T cell epitope for treatment of allergies | Mar 7, 2013 | Issued |
Array
(
[id] => 8915950
[patent_doc_number] => 20130177575
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2013-07-11
[patent_title] => 'NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS'
[patent_app_type] => utility
[patent_app_number] => 13/780994
[patent_app_country] => US
[patent_app_date] => 2013-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 21
[patent_figures_cnt] => 21
[patent_no_of_words] => 14472
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13780994
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/780994 | NOVEL THERAPEUTIC TARGET AND DIAGNOSTIC MARKER FOR ASTHMA AND RELATED CONDITIONS | Feb 27, 2013 | Abandoned |